Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Profound Medical (PROF) Non-Current Deferred Tax Liability (2023 - 2024)

Profound Medical has reported Non-Current Deferred Tax Liability over the past 2 years, most recently at $59000.0 for Q3 2024.

For Q3 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $59000.0; the TTM value through Sep 2024 reached $59000.0, changed N/A, while the annual FY2023 figure was $59000.0, N/A changed from the prior year.
Non-Current Deferred Tax Liability for Q3 2024 was $59000.0 at Profound Medical, roughly flat from $59000.0 in the prior quarter.
Over five years, Non-Current Deferred Tax Liability peaked at $59000.0 in Q4 2023 and troughed at $59000.0 in Q4 2023.